SNSF-funded research produced a total of 13,938 publications in 2020, 63% of which are freely accessible. Upgrades in monitoring capabilities make the positive trend towards more Open Access (OA) more readily visible.
The good news is you’ve published your manuscript! The bad news? With two million other new research articles likely to be published this year, you face steep competition for readers, downloads, citations and media attention.
Scientists who collaborate locally publish more papers and are more highly cited than those who engage in long-distance relationships.
It's a tale for all time. What might be the greatest scam in history or, at least, the one that threatens to take history down with it. Think of it as the climate-change scam that beat science, big time. Scientists have been seriously investigating the subject of human-made climate change since the late 1950s and political leaders have been discussing it for nearly as long. In 1961, Alvin Weinberg, the director of the Oak Ridge National Laboratory, called carbon dioxide one of the "big problems"
Growing competition means U.S. must decide where to excel.
Biochemist Juliet Gerrard will advise the government on key science issues when she takes up the position next month.
Thousands of abstracts of conference presentations, most by authors in China, were declared flawed.
The rate of retractions of scientific papers has been growing over the past decade, suggestive to some of a crisis of confidence in science. Can we no longer trust the scientific literature?
Scientists around the world fear the Mexican government is trying to send a message to those who would dare question it.
A recent article in the Israel Journal of Health Policy Research (IJHPR), analyzes the factors behind a recent surge in high quality publications by Israeli researchers, which have also informed global efforts to control the COVID-19 pandemic. This blog highlights two of those factors which may be particularly relevant for researchers, research institutions, and research authorities in other countries.
As we slowly emerge from the coronavirus outbreak in Europe, one thing is clear - it has brought to the front various aspects of gender equality issues in Research and Innovation (R&I), writes Marcela Linkova.
Many doctors on the front lines say unvaccinated patients in their 20s and 30s are becoming more severely ill, and more quickly. But comprehensive data is lacking.
Getting ready to unveil the 21st “Breakthrough of the Year”...
Being frozen out of Horizon Europe and Erasmus+ for over three years has taken its toll on the country’s academics.
Some university presses rely on subsidies because their mission is to expand knowledge - not to publish blockbusters.
The psychologist Steven Pinker has long believed we should be more optimistic - and even current crises do not dissuade him.
Lawsuits have an intimidating effect on an already difficult enterprise.
Scientific publishers charge so much that even Harvard can't afford it anymore. A new publishing infrastructure could help.
What is the Research Organization Registry (ROR) and why do we need it? Learn more from the team behind it (CDL, Crossref, DataCite, and Digital Science) in this interview with Alice Meadows.
Being based in an English-speaking country is the most significant factor in boosting a researcher’s likelihood of being published in a high-impact medical journal, a study has suggested.
The sudden, unexplained removal of a research paper on private equity firms buying dermatology practices has raised questions about corporate influence.
Expert behind vaccine confidence report points to halting of Oxford Covid trial as example.
A new study finds that very few scientists (fewer than 1%) manage to publish a paper every year. But these scientists dominate the research journals, having their names on 41% of all papers.
The days of open science have arrived and it is time to move from pay-to-read to free-to-read, says EU's R&D Commissioner. But publishers want to keep their subscriptions.
